Search Results (Refine Search)
- Keyword (text search): cpe:2.3:a:bmc:remedy_mid-tier:9.1:sp3:*:*:*:*:*:*
- CPE Name Search: true
Vuln ID | Summary | CVSS Severity |
---|---|---|
CVE-2017-17678 |
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility. Published: May 19, 2021; 10:15:07 AM -0400 |
V4.0:(not available) V3.1: 6.1 MEDIUM V2.0: 4.3 MEDIUM |
CVE-2017-17677 |
BMC Remedy 9.1SP3 is affected by authenticated code execution. Authenticated users that have the right to create reports can use BIRT templates to run code. Published: May 19, 2021; 10:15:07 AM -0400 |
V4.0:(not available) V3.1: 8.8 HIGH V2.0: 6.5 MEDIUM |
CVE-2017-17675 |
BMC Remedy Mid Tier 9.1SP3 is affected by log hijacking. Remote logging can be accessed by unauthenticated users, allowing for an attacker to hijack the system logs. This data can include user names and HTTP data. Published: May 19, 2021; 10:15:07 AM -0400 |
V4.0:(not available) V3.1: 5.3 MEDIUM V2.0: 5.0 MEDIUM |
CVE-2017-17674 |
BMC Remedy Mid Tier 9.1SP3 is affected by remote and local file inclusion. Due to the lack of restrictions on what can be targeted, the system can be vulnerable to attacks such as system fingerprinting, internal port scanning, Server Side Request Forgery (SSRF), or remote code execution (RCE). Published: May 19, 2021; 10:15:07 AM -0400 |
V4.0:(not available) V3.1: 9.8 CRITICAL V2.0: 7.5 HIGH |